Biomarin Pharmaceutical Inc. · NASDAQ:BMRN

BlackRock, Inc. reported a 9.10% stake in Biomarin Pharmaceutical Inc. (Schedule 13G/A)

Event Dec 31, 2025 · Filed Jan 21, 2026

BlackRock, Inc. reported a 9.10% stake in Biomarin Pharmaceutical Inc., 17,560,751 shares, as a passive investor on Dec 31, 2025. Filed Jan 21, 2026 (Schedule 13G/A).

Stake
9.10%
Shares
17,560,751
Intent
Passive
What changed
Stake changed

The filing in full

HolderStakeShares
BlackRock, Inc.9.10%17,560,751

Source

View original at SEC

Related